Chitosan Ascorbate Nanoparticles for the Vaginal Delivery of Antibiotic Drugs in Atrophic Vaginitis [PDF]
Marine Drugs, 2017 The aim of the present work was the development of chitosan ascorbate nanoparticles (CSA NPs) loaded into a fast-dissolving matrix for the delivery of antibiotic drugs in the treatment of atrophic vaginitis. CSA NPs loaded with amoxicillin trihydrate (AX)
Silvia Rossi +5 more
doaj +6 more sources
Investigation of Fructus sophorae extract’s therapeutic mechanism in atrophic vaginitis based on network pharmacology and experimental validation [PDF]
Frontiers in PharmacologyObjectiveThis study systematically elucidates the therapeutic mechanism of Fructus sophorae extract (FSE) against atrophic vaginitis (AV) by integrating network pharmacology with in vitro experimental validation.MethodsPotential drug targets of FS and AV-
Liu Jianxun, Fan Xiaodi, Zhang Yehao
exaly +4 more sources
Journal of Research in Medical Sciences, 2015 Background: Atrophic vaginitis is a disease, which affects up to 50% of postmenopausal women. This study compared the effectiveness and user-friendliness of Vagifem (an estradiol vaginal tablet) and vaginal estrogen cream in the treatment of atrophic ...
Pardis Hosseinzadeh +3 more
doaj +2 more sources
Zdravniški Vestnik, 2018 Background: Due to the defficiency of sex hormone estrogen after the menopause, the quality of woman's life dramatically decreases. Atrophic vaginitis in particular is a frequent cause of problems in these women's sex life. Methods: The gynecologist can
Lucija Vrabič-Dežman
doaj +2 more sources
Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause [PDF]
Clinics and PracticeBackground and Objectives: Genitourinary syndrome of menopause (GSM), previously known as vulvovaginal atrophy, is a chronic, progressive hypoestrogenic condition affecting vulvovaginal, urinary and sexual health in women. Common symptoms include vaginal
Jissy Cyriac, Richa Sood
doaj +2 more sources
Vaginal Estrogen Therapy for the Treatment of Atrophic Vaginitis [PDF]
Journal of Women's Health, 2009 The prevalence of atrophic vaginitis (AV) is particularly high among postmenopausal women who experience decreased ovarian estrogen production. This common menopausal condition, which is often underreported and underdiagnosed, is caused by estrogen-related changes to the vaginal epithelium and can adversely affect quality of life. An accurate diagnosis
exaly +3 more sources
Proteolytic Imbalance of the MMP/E-Cadherin Axis in Genitourinary Syndrome of Menopause: A Cross-Sectional Study [PDF]
International Journal of Women's HealthPeiqiong Chen,1,2 Yizhou Huang,1,2 Tao Zhang,1,2 Cheng Wu,1,2 Linjuan Ma,1,2 Yibing Lan,1,2 Jianhong Zhou1,2 1Department of Gynecology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Zhejiang ...
Chen P +6 more
doaj +2 more sources
Comprehensive Evaluation of the Utility of Cell Block Use in ThinPrep Liquid-Based Cervical Specimens [PDF]
Türk Patoloji DergisiObjective: The Papanicolaou (PAP) smear remains the cornerstone of early detection and prevention in cervical cancer screening, Today, liquid-based cytology (LBC) techniques are more widely used for this purpose.
Yasemin AKCA, Evren UZUN, Suna ERKILIC
doaj +2 more sources
Effect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy [PDF]
Journal of Ayurveda and Integrative MedicineBackground: Vaginal atrophy is a common condition in postmenopausal women due to low estrogen causing dryness, irritation, infections, and painful intercourse.
Elahe Naderi-afshar +6 more
doaj +2 more sources
Atrophic Vaginitis in Breast Cancer Survivors: A Difficult Survivorship Issue [PDF]
Journal of Personalized Medicine, 2015 Maryam Lustberg +2 more
exaly +2 more sources